Steris agrees to acquire Pennsylvania-based Xodus Medical for $2.1 billion in a debt-funded transaction expected to close by December 31, 2026. The purchase expands Steris' healthcare consumables portfolio with surgical-safety devices, including the Pink Pad system, from a company generating $245 million in projected 2026 revenue. Expected tax benefits with a net present value of $300 million bring the net purchase price down to $1.8 billion.
Acquisition terms and expected timeline
- ▪The projected $300 million net present value of cash tax benefits reduces Steris' effective acquisition cost for Xodus Medical from $2.1 billion to $1.8 billion
- ▪Steris plans to fund its $2.1 billion acquisition of Xodus Medical primarily through debt
- ▪Steris expects its $2.1 billion acquisition of Xodus Medical to close by December 31, 2026, subject to regulatory approvals
- ▪Medical equipment manufacturer Steris signed an agreement to acquire privately held, Pennsylvania-based Xodus Medical for $2.1 billion
Xodus Medical products and revenue
- ▪Steris' acquisition of Xodus Medical expands Steris' portfolio by adding single-use surgical products and consumables designed to improve safety for hospital patients and operating-room staff
- ▪Xodus Medical is best known for its Pink Pad system, which secures and stabilizes patients on operating tables to reduce slipping and pressure-related injuries
Strategic impact and analyst outlook
- ▪Stephens analyst Steven Etoch stated that Steris may increase Xodus Medical's sales by utilizing Steris' larger distribution network and established hospital relationships
- ▪Steris' purchase of Xodus Medical strengthens Steris' strategy to expand its sterilization and healthcare consumables business in hospitals and laboratories
Story comments
Loading comments…